Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 1;201(9):1155-1157.
doi: 10.1164/rccm.201911-2149LE.

Optimizing β-Lactams against Tuberculosis

Affiliations

Optimizing β-Lactams against Tuberculosis

Veronique R de Jager et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Fourteen-day mycobactericidal activity of intravenous meropenem (Mero) 6 g once daily over 6 hours versus 2 g every 8 hours, compared with that of ertapenem (Erta) 1 g once daily intramuscularly and isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE) dosed once daily according to standard weight bands. All Mero- and Erta-containing groups received amoxicillin plus clavulanic acid orally twice daily. The darker blue lines represent the estimated daily on-treatment change in colony-forming units [log10cfu], adjusted for baseline cfu, age, body mass index, sex, and study. The lighter blue shadows are the associated 95% confidence bands. The solid squares represent the time point of sputum collection. We used a single joint linear mixed-effects model, taking into account the correlation between observations from each participant.

References

    1. Diacon AH, van der Merwe L, Barnard M, von Groote-Bidlingmaier F, Lange C, García-Basteiro AL, et al. β-Lactams against tuberculosis—new trick for an old dog? N Engl J Med. 2016;375:393–394. - PubMed
    1. World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. 2019. [accessed 2019 Aug]. Available from: https://www.who.int/tb/publications/2019/consolidated-guidelines-drug-re... - PubMed
    1. van Rijn SP, Srivastava S, Wessels MA, van Soolingen D, Alffenaar JC, Gumbo T. Sterilizing effect of ertapenem-clavulanate in a hollow-fiber model of tuberculosis and implications on clinical dosing. Antimicrob Agents Chemother. 2017;61:e02039–16. - PMC - PubMed
    1. Zuur MA, Ghimire S, Bolhuis MS, Wessels AMA, van Altena R, de Lange WCM, et al. Pharmacokinetics of 2,000 milligram ertapenem in tuberculosis patients. Antimicrob Agents Chemother. 2018;62:e02250-17. - PMC - PubMed

MeSH terms